Endocrine regulation and metabolic mechanisms of osteopontin in the development and progression of osteosarcoma, metastasis and prognosis

Osteosarcoma is the most common type of malignant bone tumor, occurring in adolescents and patients over 60. It has a bimodal onset and a poor prognosis, and its development has not yet been fully explained. Osteopontin (OPN) is a high protein consisting of 314 amino acid residues with a negative ch...

Full description

Bibliographic Details
Main Authors: Zhuce Shao, Shuxiong Bi
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-01-01
Series:Frontiers in Endocrinology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fendo.2022.1100063/full
_version_ 1797954112635011072
author Zhuce Shao
Shuxiong Bi
author_facet Zhuce Shao
Shuxiong Bi
author_sort Zhuce Shao
collection DOAJ
description Osteosarcoma is the most common type of malignant bone tumor, occurring in adolescents and patients over 60. It has a bimodal onset and a poor prognosis, and its development has not yet been fully explained. Osteopontin (OPN) is a high protein consisting of 314 amino acid residues with a negative charge and is involved in many biological activities. OPN is not only an essential part of the regulation of the nervous system and endocrine metabolism of skeletal cells. Still, it is also involved in several other important biological activities, such as the division, transformation, and proliferation of skeletal cells and their associated cells, such as bone tumor cells, including bone marrow mesenchymal stem cells, hematopoietic stem cells, osteoblasts, and osteoclasts. Osteoblasts and osteocytes. Recent studies have shown a strong correlation between OPN and the development and progression of many skeletal diseases, such as osteosarcoma and rheumatoid arthritis. This review aims to understand the mechanisms and advances in the role of OPN as a factor in the development, progression, metastasis, and prognosis of osteosarcoma in an attempt to provide a comprehensive summary of the mechanisms by which OPN regulates osteosarcoma progression and in the hope of contributing to the advancement of osteosarcoma research and clinical treatment.
first_indexed 2024-04-10T23:12:27Z
format Article
id doaj.art-923d9352a6f4461bb12cbb13e2a2677e
institution Directory Open Access Journal
issn 1664-2392
language English
last_indexed 2024-04-10T23:12:27Z
publishDate 2023-01-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Endocrinology
spelling doaj.art-923d9352a6f4461bb12cbb13e2a2677e2023-01-13T04:33:55ZengFrontiers Media S.A.Frontiers in Endocrinology1664-23922023-01-011310.3389/fendo.2022.11000631100063Endocrine regulation and metabolic mechanisms of osteopontin in the development and progression of osteosarcoma, metastasis and prognosisZhuce ShaoShuxiong BiOsteosarcoma is the most common type of malignant bone tumor, occurring in adolescents and patients over 60. It has a bimodal onset and a poor prognosis, and its development has not yet been fully explained. Osteopontin (OPN) is a high protein consisting of 314 amino acid residues with a negative charge and is involved in many biological activities. OPN is not only an essential part of the regulation of the nervous system and endocrine metabolism of skeletal cells. Still, it is also involved in several other important biological activities, such as the division, transformation, and proliferation of skeletal cells and their associated cells, such as bone tumor cells, including bone marrow mesenchymal stem cells, hematopoietic stem cells, osteoblasts, and osteoclasts. Osteoblasts and osteocytes. Recent studies have shown a strong correlation between OPN and the development and progression of many skeletal diseases, such as osteosarcoma and rheumatoid arthritis. This review aims to understand the mechanisms and advances in the role of OPN as a factor in the development, progression, metastasis, and prognosis of osteosarcoma in an attempt to provide a comprehensive summary of the mechanisms by which OPN regulates osteosarcoma progression and in the hope of contributing to the advancement of osteosarcoma research and clinical treatment.https://www.frontiersin.org/articles/10.3389/fendo.2022.1100063/fullosteopontinosteosarcomaendocrine regulationmetabolismcancer
spellingShingle Zhuce Shao
Shuxiong Bi
Endocrine regulation and metabolic mechanisms of osteopontin in the development and progression of osteosarcoma, metastasis and prognosis
Frontiers in Endocrinology
osteopontin
osteosarcoma
endocrine regulation
metabolism
cancer
title Endocrine regulation and metabolic mechanisms of osteopontin in the development and progression of osteosarcoma, metastasis and prognosis
title_full Endocrine regulation and metabolic mechanisms of osteopontin in the development and progression of osteosarcoma, metastasis and prognosis
title_fullStr Endocrine regulation and metabolic mechanisms of osteopontin in the development and progression of osteosarcoma, metastasis and prognosis
title_full_unstemmed Endocrine regulation and metabolic mechanisms of osteopontin in the development and progression of osteosarcoma, metastasis and prognosis
title_short Endocrine regulation and metabolic mechanisms of osteopontin in the development and progression of osteosarcoma, metastasis and prognosis
title_sort endocrine regulation and metabolic mechanisms of osteopontin in the development and progression of osteosarcoma metastasis and prognosis
topic osteopontin
osteosarcoma
endocrine regulation
metabolism
cancer
url https://www.frontiersin.org/articles/10.3389/fendo.2022.1100063/full
work_keys_str_mv AT zhuceshao endocrineregulationandmetabolicmechanismsofosteopontininthedevelopmentandprogressionofosteosarcomametastasisandprognosis
AT shuxiongbi endocrineregulationandmetabolicmechanismsofosteopontininthedevelopmentandprogressionofosteosarcomametastasisandprognosis